Xenon Pharmaceuticals, Inc. (XENE)
60.54
-0.23
(-0.38%)
USD |
NASDAQ |
Aug 24, 16:00
60.54
0.00 (0.00%)
After-Hours: 20:00
Xenon Pharmaceuticals Shareholders Equity (Quarterly) : 1.242B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.242B |
| March 31, 2026 | 1.338B |
| December 31, 2025 | 581.76M |
| September 30, 2025 | 559.51M |
| June 30, 2025 | 633.98M |
| March 31, 2025 | 703.96M |
| December 31, 2024 | 754.90M |
| September 30, 2024 | 797.81M |
| June 30, 2024 | 844.05M |
| March 31, 2024 | 887.70M |
| December 31, 2023 | 927.92M |
| September 30, 2023 | 636.59M |
| June 30, 2023 | 646.46M |
| March 31, 2023 | 686.94M |
| December 31, 2022 | 721.50M |
| September 30, 2022 | 753.12M |
| June 30, 2022 | 785.79M |
| March 31, 2022 | 541.85M |
| December 31, 2021 | 550.03M |
| September 30, 2021 | 248.94M |
| June 30, 2021 | 256.98M |
| March 31, 2021 | 276.28M |
| December 31, 2020 | 171.36M |
| September 30, 2020 | 182.02M |
| June 30, 2020 | 189.30M |
| Date | Value |
|---|---|
| March 31, 2020 | 187.98M |
| December 31, 2019 | 91.98M |
| September 30, 2019 | 74.56M |
| June 30, 2019 | 82.79M |
| March 31, 2019 | 92.31M |
| December 31, 2018 | 103.30M |
| September 30, 2018 | 111.16M |
| June 30, 2018 | 50.62M |
| March 31, 2018 | 28.50M |
| December 31, 2017 | 35.93M |
| September 30, 2017 | 43.30M |
| June 30, 2017 | 50.45M |
| March 31, 2017 | 57.20M |
| December 31, 2016 | 63.90M |
| September 30, 2016 | 69.31M |
| June 30, 2016 | 52.66M |
| March 31, 2016 | 58.16M |
| December 31, 2015 | 61.03M |
| September 30, 2015 | 64.46M |
| June 30, 2015 | 64.35M |
| March 31, 2015 | 68.97M |
| December 31, 2014 | 72.78M |
| September 30, 2014 | 34.98M |
| June 30, 2014 | 27.11M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Sirona Biochem Corp. | -- |
| Psyence Biomedical Ltd. | 11.87M |
| Aurinia Pharmaceuticals, Inc. | 614.86M |
| enGene Therapeutics, Inc. | 255.17M |
| Medicus Pharma Ltd. | -1.243M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.296B |
| Total Liabilities (Quarterly) | 53.38M |
| Debt to Equity Ratio | 0.0052 |
| Current Ratio | 21.02 |
| Net Debt Paydown Yield | 0.01% |